In-house nucleic acid amplification tests for the detection of Mycobacterium tuberculosis in sputum specimens:: meta-analysis and meta-regression -: art. no. 55

被引:132
作者
Flores, LL
Pai, M
Colford, JM
Riley, LW [1 ]
机构
[1] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis, Berkeley, CA 94720 USA
[2] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA 94720 USA
[3] IPN, CINVESTAV, Div Mol Biomed, Mexico City 07738, DF, Mexico
[4] San Francisco Gen Hosp, Div Pulm & Crit Care Med, San Francisco, CA 94110 USA
关键词
D O I
10.1186/1471-2180-5-55
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: More than 200 studies related to nucleic acid amplification (NAA) tests to detect Mycobacterium tuberculosis directly from clinical specimens have appeared in the world literature since this technology was first introduced. NAA tests come as either commercial kits or as tests designed by the reporting investigators themselves (in-house tests). In-house tests vary widely in their accuracy, and factors that contribute to heterogeneity in test accuracy are not well characterized. Here, we used meta-analytical methods, including meta-regression, to identify factors related to study design and assay protocols that affect test accuracy in order to identify those factors associated with high estimates of accuracy. Results: By searching multiple databases and sources, we identified 2520 potentially relevant citations, and analyzed 84 separate studies from 65 publications that dealt with in-house NAA tests to detect M. tuberculosis in sputum samples. Sources of heterogeneity in test accuracy estimates were determined by subgroup and meta-regression analyses. Among 84 studies analyzed, the sensitivity and specificity estimates varied widely; sensitivity varied from 9.4% to 100%, and specificity estimates ranged from 5.6% to 100%. In the meta-regression analysis, the use of IS6110 as a target, and the use of nested PCR methods appeared to be significantly associated with higher diagnostic accuracy. Conclusion: Estimates of accuracy of in-house NAA tests for tuberculosis are highly heterogeneous. The use of IS6110 as an amplification target, and the use of nested PCR methods appeared to be associated with higher diagnostic accuracy. However, the substantial heterogeneity in both sensitivity and specificity of the in-house NAA tests rendered clinically useful estimates of test accuracy difficult. Future development of NAA-based tests to detect M. tuberculosis from sputum specimens should take into consideration these findings in improving accuracy of in-house NAA tests.
引用
收藏
页数:9
相关论文
共 76 条
  • [1] CHARACTERIZATION OF A DNA PROBE FOR DETECTION OF MYCOBACTERIUM-TUBERCULOSIS COMPLEX IN CLINICAL-SAMPLES BY POLYMERASE CHAIN-REACTION
    ALTAMIRANO, M
    KELLY, MT
    WONG, A
    BESSUILLE, ET
    BLACK, WA
    SMITH, JA
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (08) : 2173 - 2176
  • [2] INACTIVATION OF POLYMERASE INHIBITORS FOR MYCOBACTERIUM-TUBERCULOSIS DNA AMPLIFICATION IN SPUTUM BY USING CAPTURE RESIN
    AMICOSANTE, M
    RICHELDI, L
    TRENTI, G
    PAONE, G
    CAMPA, M
    BISETTI, A
    SALTINI, C
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (03) : 629 - 630
  • [3] POLYMERASE CHAIN-REACTION FOR DETECTION OF MYCOBACTERIUM-TUBERCULOSIS IN SPUTUM
    ANDERSEN, AB
    THYBO, S
    GODFREYFAUSSETT, P
    STOKER, NG
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1993, 12 (12) : 922 - 927
  • [4] Comparison of culture and acid-fast bacilli stain to PCR for detection of Mycobacterium tuberculosis in clinical samples
    Aslanzadeh, J
    de la Viuda, M
    Fille, M
    Smith, WB
    Namdari, H
    [J]. MOLECULAR AND CELLULAR PROBES, 1998, 12 (04) : 207 - 211
  • [5] CLINICAL-EVALUATION OF A MYCOBACTERIUM-TUBERCULOSIS PCR ASSAY
    BEIGE, J
    LOKIES, J
    SCHABERG, T
    FINCKH, U
    FISCHER, M
    MAUCH, H
    LODE, H
    KOHLER, B
    ROLFS, A
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (01) : 90 - 95
  • [6] BRISSONNOEL A, 1989, LANCET, V2, P1069
  • [7] Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P593
  • [8] Chaiprasert A, 1996, ASIA-PAC J MOL BIOL, V4, P250
  • [9] Choi YJ, 1996, AM J CLIN PATHOL, V105, P200
  • [10] LARGE-SCALE USE OF POLYMERASE CHAIN-REACTION FOR DETECTION OF MYCOBACTERIUM-TUBERCULOSIS IN A ROUTINE MYCOBACTERIOLOGY LABORATORY
    CLARRIDGE, JE
    SHAWAR, RM
    SHINNICK, TM
    PLIKAYTIS, BB
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (08) : 2049 - 2056